Foresight Diagnostics, a leader in ultra-sensitive minimal residual disease (MRD) detection technology, today announced the launch of SHORTEN-ctDNA, a clinical trial at Columbia University.1 The study ...
SOLVE FSHD, a venture philanthropy organization dedicated to catalyzing innovation and overcoming barriers to accelerate new therapies for facioscapulohumeral muscular dystrophy (FSHD), is calling on ...
According to the study, metabolic dysfunction-associated steatotic liver disease (MASLD)— a condition where fat builds up in ...
Experts in a government lab are taking an extremely close look at pouch battery cells — using advanced imaging tech — with the goal to better understand how they age. The analysis method is ...
However, developing a reliable liquid biopsy test has proven challenging due to the complexity of blood-based biomarkers. In ...
Dr Paul T Francis, Dementia Research Laboratory, Division of Biomolecular Sciences, Guy’s, King’s and St Thomas’ Schools of Biomedical Sciences, King’s College, St Thomas Street, London SE1 9RT, UK.
The management of these infections lends itself to more direct or topical therapy for a number of reasons, including the ability to achieve high local drug concentrations at the site of the ...